Akèy › Kansè poumon › Connecticut › Bridgeport
Etid klinik pou Kansè poumon nan Bridgeport, CT
13 etid pou Kansè poumon ap chèche patisipan nan sit nan ak bò kote Bridgeport (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Ap rekriteFaz 3
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 mi lwen
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5 mi lwen
- Stony Brook University Medical Center, Stony Brook · 18 mi lwen
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Stony Brook University Medical Center, Stony Brook · 18 mi lwen
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Ap rekriteFaz 3
- Stony Brook University Medical Center, Stony Brook · 18 mi lwen
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Ap rekriteFaz 3
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 mi lwen
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5 mi lwen
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Ap rekriteFaz 1
- Smilow Cancer Hospital - Trumbull, Trumbull · 4 mi lwen
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Ap rekriteFaz 3
- University Hospital at Stony Brook ( Site 0054), Stony Brook · 18 mi lwen
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Ap rekriteFaz 2/3
- Suny-Stony Brook University Cancer Center, Stony Brook · 18 mi lwen
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
Ap rekriteFaz 1/2
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 mi lwen
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Ap rekriteFaz 3
- Stony Brook University Medical Center, Stony Brook · 18 mi lwen
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 mi lwen
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5 mi lwen
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 mi lwen
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5 mi lwen
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2/3
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 mi lwen
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5 mi lwen
Definitive Radiation for High-Risk Spine Metastases
Ap rekriteFaz 2
- Stony Brook University Hospital, Stony Brook · 18 mi lwen
Etid Kansè poumon nan lòt vil
- Houston, TX78 etid
- Boston, MA62 etid
- New York City, NY60 etid
- Los Angeles, CA45 etid
- Washington, DC41 etid
- Arlington, VA41 etid
- Chicago, IL41 etid
- Nashville, TN40 etid
- Baltimore, MD40 etid
- St. Louis, MO39 etid
- Columbus, OH37 etid
- Philadelphia, PA36 etid
Lòt etid nan Bridgeport
- Kansè nan tete21 etid
- Kansè Poumon ki pa ti selil14 etid
- Leksemi mieloïd egi12 etid
- Maladi kadyovaskilè9 etid
- Karsinòm selil skuamèz tèt ak kou8 etid
- Kansè (tout kalite)8 etid
- Kansè Metastatik7 etid
- Ensifizyans kadyak7 etid
- Aneurism sèvo6 etid
- Kansè pwostat6 etid
- Myelom Miltip6 etid
- Kansè san5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.